Professor Per I. Arvidsson
Per I Arvidsson is Director of the national Swedish Drug Discovery & Development Platform at Science for Life Laboratory (SciLifeLab DDD). He is also a fractional research professor at the College of Health Science, UKZN, and South Africa. Before joining SciLifeLab & Karolinska Institutet in 2013 to set up the SciLifeLab DDD platform, Prof. Arvidsson held various roles at the CNS & Pain iMED at AstraZeneca, Södertälje, the last being Director for late-stage pre-clinical and clinical neuroscience drug discovery. His accolades include several professorship positions at Uppsala University in Sweden and postdoctoral studies with Prof. D. Seebach at ETH Zurich, Switzerland.
Prof. Arvidsson is named inventor on some 15+ patent applications, and co-author to some 100 peer-reviewed publications, two of which have won “most cited papers” awards.